Literature DB >> 15664916

Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro.

Ashraf S Ibrahim1, Brad Spellberg, Valentina Avanessian, Yue Fu, John E Edwards.   

Abstract

Rhizopus oryzae is the most common cause of zygomycosis, a life-threatening infection that usually occurs in immunocompromised patients. A characteristic hallmark of zygomycosis is angioinvasion by the fungus, resulting in thrombosis and subsequent tissue necrosis. Interactions between R. oryzae and vascular endothelial cells are therefore likely of central importance to the organism's pathogenetic strategy. We studied the ability of R. oryzae to adhere to and damage human umbilical vein endothelial cells (HUVECs) in vitro. We report that R. oryzae spores and germ tubes adhere to HUVECs, whereas only spores adhere to subendothelial matrix proteins. Additionally, R. oryzae damages endothelial cells. This endothelial cell damage requires direct contact and subsequent phagocytosis of the fungus. Surprisingly, R. oryzae viability was not required for damage, but phagocytosis was required for dead R. oryzae to cause damage. These results elucidate the nature of R. oryzae-endothelial cell interactions, which are likely central to the angioinvasion and tissue necrosis seen during zygomycotic infections. The fact that dead R. oryzae damage human endothelial cells may, in part, explain the lack of efficacy of fungicidal agents during clinical disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664916      PMCID: PMC547117          DOI: 10.1128/IAI.73.2.778-783.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Interactions of Aspergillus fumigatus with endothelial cells: internalization, injury, and stimulation of tissue factor activity.

Authors:  Leila M Lopes Bezerra; Scott G Filler
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

2.  Binding of human fibronectin to Aspergillus fumigatus conidia.

Authors:  M C Peñalver; J E O'Connor; J P Martinez; M L Gil
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 3.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

4.  Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule.

Authors:  A S Ibrahim; S G Filler; M S Alcouloumre; T R Kozel; J E Edwards; M A Ghannoum
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

5.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

6.  Rhinocerebral invasive mycosis: occurrence in immunocompetent individuals.

Authors:  S Hussain; N Salahuddin; I Ahmad; I Salahuddin; R Jooma
Journal:  Eur J Radiol       Date:  1995-07       Impact factor: 3.528

7.  Cloning and functional characterization of the Rhizopus oryzae high affinity iron permease (rFTR1) gene.

Authors:  Yue Fu; Helen Lee; Mary Collins; Huei-Fung Tsai; Brad Spellberg; John E Edwards; Kyung J Kwon-Chung; Ashraf S Ibrahim
Journal:  FEMS Microbiol Lett       Date:  2004-06-01       Impact factor: 2.742

8.  Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components.

Authors:  J P Bouchara; N A Oumeziane; J C Lissitzky; G Larcher; G Tronchin; D Chabasse
Journal:  Eur J Cell Biol       Date:  1996-05       Impact factor: 4.492

9.  Penetration and damage of endothelial cells by Candida albicans.

Authors:  S G Filler; J N Swerdloff; C Hobbs; P M Luckett
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

  9 in total
  45 in total

1.  Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis.

Authors:  Alexis Soummer; Armelle Mathonnet; Olivier Scatton; Pierre Philippe Massault; André Paugam; Virginie Lemiale; Jean Paul Mira; Eric Dannaoui; Alain Cariou; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

2.  Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.

Authors:  Guanpingsheng Luo; Teclegiorgis Gebremariam; Hongkyu Lee; Samuel W French; Nathan P Wiederhold; Thomas F Patterson; Scott G Filler; Ashraf S Ibrahim
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

Review 3.  Update on mucormycosis pathogenesis.

Authors:  Ashraf S Ibrahim; Dimitrios P Kontoyiannis
Journal:  Curr Opin Infect Dis       Date:  2013-12       Impact factor: 4.915

4.  The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.

Authors:  Mingfu Liu; Brad Spellberg; Quynh T Phan; Yue Fu; Yong Fu; Amy S Lee; John E Edwards; Scott G Filler; Ashraf S Ibrahim
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

5.  Ketoacidosis alone does not predispose to mucormycosis by Lichtheimia in a murine pulmonary infection model.

Authors:  Bianca Schulze; Günter Rambach; Volker U Schwartze; Kerstin Voigt; Katja Schubert; Cornelia Speth; Ilse D Jacobsen
Journal:  Virulence       Date:  2017-08-24       Impact factor: 5.882

Review 6.  Pathogenesis of mucormycosis.

Authors:  Ashraf S Ibrahim; Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

7.  Future directions in mucormycosis research.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis; Oliver Lortholary; Oliver Lotholary; Brad Spellberg; Georgios Petrikkos; Emmanuel Roilides; Emmanuel Roillides; Ashraf Ibrahim; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

8.  CotH3 mediates fungal invasion of host cells during mucormycosis.

Authors:  Teclegiorgis Gebremariam; Mingfu Liu; Guanpingsheng Luo; Vincent Bruno; Quynh T Phan; Alan J Waring; John E Edwards; Scott G Filler; Michael R Yeaman; Ashraf S Ibrahim
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

Review 9.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

10.  Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis.

Authors:  Ashraf S Ibrahim; Teclegiorgis Gebremariam; Mingfu Liu; Georgios Chamilos; Dimitrios Kontoyiannis; Richard Mink; Kyung J Kwon-Chung; Yue Fu; Christopher D Skory; John E Edwards; Brad Spellberg
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.